Article (Scientific journals)
Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.
Scheen, André
2010In Expert Opinion on Drug Metabolism and Toxicology, 6 (10), p. 1265-76
Peer Reviewed verified by ORBi
 

Files


Full Text
Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin..pdf
Publisher postprint (366.13 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Type 2 diabetes; Sibutramine; Arrhythmia; Heart rate; Safety; Blood pressure; Cardiovascular outcome; Obesity
Abstract :
[en] IMPORTANCE OF THE FIELD: Type 2 diabetes is an increasingly prevalent disease resulting from various complex combinations of defects in insulin secretion and insulin action. Adequate blood glucose control is necessary to minimize complications. DPP IV inhibitors (sitagliptin, vildagliptin, saxagliptin) offer new options for combined pharmacological therapy. AREAS COVERED IN THIS REVIEW: An extensive literature search was performed to analyze the potential pharmacokinetic (PK) and pharmacodynamic (PD) interactions between metformin (first-line drug for the management of type 2 diabetes) and sitagliptin (first commercialized DPP IV inhibitor). Metformin and sitagliptin may be administered together, either separately or in fixed-dose combination. WHAT THE READER WILL GAIN: Updated information about PK/PD data on metformin alone, sitagliptin alone and sitagliptin plus metformin. Metformin and sitagliptin are not prone to PK drug-drug interactions. Their co-administration, either separately or in a fixed-dose combination, improves blood glucose control more potently than either compound separately, without hypoglycemia and without increasing metformin-related gastrointestinal side effects. TAKE HOME MESSAGE: The combination sitagliptin plus metformin may be used as a first- or second-line therapy in the management of type 2 diabetes.
Disciplines :
Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
English
Title :
Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.
Publication date :
2010
Journal title :
Expert Opinion on Drug Metabolism and Toxicology
ISSN :
1742-5255
eISSN :
1744-7607
Publisher :
Informa Healthcare, United Kingdom
Volume :
6
Issue :
10
Pages :
1265-76
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 December 2010

Statistics


Number of views
117 (2 by ULiège)
Number of downloads
4 (1 by ULiège)

Scopus citations®
 
38
Scopus citations®
without self-citations
21
OpenCitations
 
23

Bibliography


Similar publications



Contact ORBi